Conformis
-
Recon
Scaling a Personalized Portfolio: restor3d Completes Key Initiative Following Conformis Acquisition
Legacy Conformis’ casted femoral implant (left), restor3d 3-D printed femoral implant (right) DURHAM, N.C., January 16, 2024–(BUSINESS WIRE)–On September 5,…
Read More » -
Financial
restor3d Completes Acquisition of Conformis
Combination Creates the World’s Preeminent Producer of Personalized Orthopedic Medical Devices, with Unmatched Additive Manufacturing Capabilities DURHAM, North Carolina and…
Read More » -
Financial
Conformis Announces Definitive Agreement to be Acquired by restor3d for a Purchase Price of $2.27 Per Share in Cash
Combination creates a leading personalized 3D-printed orthopedic medical device company DURHAM, N.C. and BILLERICA, Mass., June 23, 2023 (GLOBE NEWSWIRE)…
Read More » -
Recon
Conformis Announces First Procedure Performed Using New Actera™ Hip System
First Actera™ procedure underscores company’s ongoing commitment to advancing joint replacement technology by leveraging its data-driven approach and surgical planning expertise…
Read More » -
Recon
Conformis Announces Full Commercial Launch of Imprint™
Conformis’ Imprint™ knee system introduces the new “Made-to-Measure” product category option for Total Knee Arthroplasty (TKA). BILLERICA, Mass., Nov. 17,…
Read More » -
Recon
Conformis Actera™ Hip System Receives 510(k) Clearance from the U.S. Food and Drug Administration
New design adds increasingly more common tri-taper femoral stem design and direct anterior approaches to the expanding Conformis family of…
Read More » -
Recon
Conformis Announces New Agreement with Vizient for Personalized Orthopedic Implants
Agreement enables interested Vizient members, including academic medical centers, acute care facilities, and ambulatory surgery centers (ASCs), to purchase Conformis…
Read More » -
Recon
Gary Fischetti nominated to join Conformis’ Board of Directors
BILLERICA, Mass., March 11, 2022 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS), announced today that Gary P. Fischetti has been nominated…
Read More » -
Recon
New Clinical Study Finds Bilateral Knee Patients Prefer Conformis’ Fully Personalized Solution Over Competitive Off-the-Shelf Implants by a Factor of Over 10 to 1
Study included only patients with a fully personalized Conformis implant in one knee after previously receiving a competitive off-the-shelf implant in…
Read More » -
Financial
Conformis, Inc. Provides Business Update and Initial Expectations for 2022
Company Launches Innovative Image-to-Implant® Platinum Services℠ Program to Better Serve Patients and Surgeons BILLERICA, Mass., Jan. 06, 2022 (GLOBE NEWSWIRE) —…
Read More » -
Recon
Conformis, Inc. Appoints James Paiva as its new Vice President of U.S. Marketing; Inducement Grant Reported
BILLERICA, Mass., Nov. 08, 2021 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS) announced today that the Company has appointed James Paiva as its new…
Read More » -
Recon
Conformis, Inc. Announces Strong Clinical Study Results for Its Personalized Knee Implants
A retrospective review of 540 procedures performed demonstrated 98.5% Implant Survivorship and 89.0% Patient Satisfaction for the Conformis patient-specific iTotal®…
Read More » -
Recon
Conformis, Inc. Announces First Procedure Performed Using the Identity Imprint™ Knee Replacement System
BILLERICA, Mass., Aug. 18, 2021 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS) today announced the first procedure with the new Conformis Identity…
Read More » -
Recon
Conformis, Inc. Announces Exclusive Distribution Agreement in China
New Agreement expands Conformis’ global reach and brings patient-specific knee replacement systems to the largest market in the Asia-Pacific region…
Read More » -
Recon
Orthopaedic Surgeon, Dr. Robert Snyder, performs the first outpatient Total Knee Arthroplasty using the Conformis iTotal G2 Patient-Specific Knee Replacement Prosthesis and Cutting Jigs
NEWPORT NEWS, Va., May 5, 2021 /PRNewswire/ — Dr. Robert J. Snyder performed the first outpatient Total Knee Arthroplasty using the Conformis iTotal G2 Patient-Specific…
Read More »